About the Product

Description


      Miratyle 50 Tablet contains Mirabegron (50mg), a beta-3 adrenergic receptor agonist used primarily in the treatment of overactive bladder (OAB). It helps alleviate symptoms such as urinary urgency, frequency, and incontinence by relaxing the bladder’s detrusor muscle, leading to improved bladder capacity and reduced involuntary contractions. Unlike traditional anticholinergics, Miratyle offers a unique and effective option for OAB treatment with a favorable side effect profile, making it suitable for patients who are intolerant or have contraindications to other OAB therapies.

Mirabegron works by targeting the beta-3 receptors in the bladder, promoting smooth muscle relaxation and helping patients regain control over bladder function. It is particularly beneficial for individuals who need long-term management of OAB and may not respond well to anticholinergic medications.

Common side effects may include: Increased blood pressure Headache Nasopharyngitis (common cold symptoms) Dizziness Constipation Serious side effects are rare but may include urinary retention or allergic reactions such as swelling, rash, or breathing difficulties. Consult your doctor if any severe or unusual symptoms develop.

Treatment of overactive bladder (OAB) with symptoms such as urinary urgency, frequency, and incontinence.

Take as prescribed by your healthcare provider. Not recommended for use in patients with uncontrolled high blood pressure. Monitor blood pressure regularly during treatment. Use with caution in patients with renal or hepatic impairment.

Store at room temperature below 25°C, in a cool, dry place. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Mirabegron 50mg Tablet in the PCD pharma franchise market?

Mirabegron 50mg Tablet has strong demand in the urology, nephrology, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on urinary health and specialty care portfolios.

Why should medical distributors include Mirabegron 50mg Tablet in their product range?

Medical distributors and agencies can benefit from growing demand for overactive bladder (OAB) management under medical supervision. Mirabegron 50mg is a beta-3 adrenergic receptor agonist used for the treatment of overactive bladder symptoms Commonly prescribed for urinary urgency, increased urinary frequency, urge urinary incontinence, and overactive bladder syndrome Helps relax the bladder muscle, improving bladder storage capacity and reducing episodes of urgency and frequent urination Frequently used as a long-term therapy in adults with urinary bladder disorders Widely prescribed by urologists, nephrologists, gynecologists, and physicians Growing awareness and diagnosis of urinary disorders continue to drive demand for specialized urology products This strengthens a comprehensive urology and urinary healthcare portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Mirabegron 50mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from specialist-driven prescriptions, long-term therapy demand, repeat orders, reliable supply chain support, and attractive margins in the urology segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.